Technical Analysis for ATAI - ATAI Life Sciences N.V.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
C | 1.57 | -6.55% | -0.11 |
ATAI closed down 6.55 percent on Friday, May 31, 2024, on 86 percent of normal volume. The stock fell below its 200 day moving average, damaging its long-term outlook by crossing under that critical trendline. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Fell Below 200 DMA | Bearish | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
200 DMA Support | Bullish | -6.55% | |
Wide Bands | Range Expansion | -6.55% | |
Oversold Stochastic | Weakness | -6.55% | |
Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | -3.68% | |
200 DMA Support | Bullish | -3.68% | |
Outside Day | Range Expansion | -3.68% | |
Wide Bands | Range Expansion | -3.68% |
Alert | Time |
---|---|
Down 1 ATR | 1 day ago |
60 Minute Opening Range Breakdown | 1 day ago |
10 DMA Resistance | 1 day ago |
Down 5% | 1 day ago |
Down 3% | 1 day ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/07/2024
atai is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai was founded in 2018 as a response to the significant unmet need and lack of innovation in the mental health treatment landscape, as well as the emergence of therapies that previously may have been overlooked or underused, including psychedelic compounds and digital therapeutics. atai is headquartered in Berlin, with offices in New York and London.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Medication Disability Mental Health Psychiatry Mental Disorder Positive Psychology Mental Health Disorders
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Medication Disability Mental Health Psychiatry Mental Disorder Positive Psychology Mental Health Disorders
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 2.85 |
52 Week Low | 1.025 |
Average Volume | 1,467,271 |
200-Day Moving Average | 1.62 |
50-Day Moving Average | 1.96 |
20-Day Moving Average | 1.83 |
10-Day Moving Average | 1.66 |
Average True Range | 0.14 |
RSI (14) | 36.71 |
ADX | 15.78 |
+DI | 14.01 |
-DI | 22.13 |
Chandelier Exit (Long, 3 ATRs) | 1.86 |
Chandelier Exit (Short, 3 ATRs) | 1.94 |
Upper Bollinger Bands | 2.19 |
Lower Bollinger Band | 1.46 |
Percent B (%b) | 0.15 |
BandWidth | 39.58 |
MACD Line | -0.11 |
MACD Signal Line | -0.09 |
MACD Histogram | -0.0201 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 1.81 | ||||
Resistance 3 (R3) | 1.82 | 1.75 | 1.77 | ||
Resistance 2 (R2) | 1.75 | 1.69 | 1.75 | 1.76 | |
Resistance 1 (R1) | 1.66 | 1.65 | 1.63 | 1.65 | 1.74 |
Pivot Point | 1.59 | 1.59 | 1.57 | 1.59 | 1.59 |
Support 1 (S1) | 1.50 | 1.53 | 1.46 | 1.49 | 1.40 |
Support 2 (S2) | 1.43 | 1.49 | 1.42 | 1.38 | |
Support 3 (S3) | 1.34 | 1.43 | 1.37 | ||
Support 4 (S4) | 1.33 |